[
    {
        "title": "Sequence-based protein-protein interaction prediction and its applications in drug discovery",
        "summary": "Aberrant protein-protein interactions (PPIs) underpin a plethora of human\ndiseases, and disruption of these harmful interactions constitute a compelling\ntreatment avenue. Advances in computational approaches to PPI prediction have\nclosely followed progress in deep learning and natural language processing. In\nthis review, we outline the state-of the-art for sequence-based PPI prediction\nmethods and explore their impact on target identification and drug discovery.\nWe begin with an overview of commonly used training data sources and techniques\nused to curate these data to enhance the quality of the training set.\nSubsequently, we survey various PPI predictor types, including traditional\nsimilarity-based approaches, and deep learning-based approaches with a\nparticular emphasis on the transformer architecture. Finally, we provide\nexamples of PPI prediction in systems-level proteomics analyses, target\nidentification, and design of therapeutic peptides and antibodies. We also take\nthe opportunity to showcase the potential of PPI-aware drug discovery models in\naccelerating therapeutic development.",
        "url": "http://arxiv.org/abs/2507.19805v1",
        "published_date": "2025-07-26T05:37:55+00:00",
        "updated_date": "2025-07-26T05:37:55+00:00",
        "categories": [
            "q-bio.BM",
            "cs.LG"
        ],
        "authors": [
            "Fran√ßois Charih",
            "James R. Green",
            "Kyle K. Biggar"
        ],
        "pdf_url": "http://arxiv.org/pdf/2507.19805v1",
        "tldr": "This review paper outlines state-of-the-art sequence-based protein-protein interaction (PPI) prediction methods, focusing on deep learning and NLP advancements like transformers, and explores their applications in target identification and drug discovery, particularly for therapeutic peptides and antibodies.",
        "explanation": "The paper provides a comprehensive overview of sequence-based PPI prediction. It covers training data sources, curation techniques, different PPI predictor types (similarity-based and deep learning-based), and applications in proteomics, target identification, and therapeutic design. A key aspect is its emphasis on the transformer architecture's impact. The paper also discusses the challenges and future trends in PPI prediction for drug development, specifically highlighting peptide and antibody engineering.",
        "interests_alignment": "While the paper focuses on protein-protein interactions rather than peptide-peptide interactions, the machine learning methodologies, particularly the use of protein language models (pLMs) and deep learning architectures like transformers, are directly relevant to my interest in machine learning for peptides and biomolecules. The application of these models to design therapeutic peptides aligns well with my research interests. Furthermore, the discussion of datasets used for PPI prediction is valuable, as similar datasets or featurization techniques might be transferable to peptide self-assembly studies.",
        "relevance_score": 7,
        "novelty_claim_score": 6,
        "clarity_score": 8,
        "potential_impact_score": 7,
        "overall_priority_score": 7
    }
]